Samantha Delgado writes about the operational side of running a small business, from filing a DBA to securing licenses, permits, insurance, and financing. She focuses on the practical, often overlooked steps that come after a business is legally formed. Samantha's goal is to help new owners avoid the compliance gaps that can cause problems down the road.
Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve...
Read Article →
Integrated AEO and GEO strategies help dental practices remain visible as patients increasingly turn to AI tools and voice assistants...
Read Article →
One fiber connector technology, from the optical engine to the box edge. Live connector demonstration at SEMICON Taiwan.SAN JOSE, Calif.,...
Read Article →
A fine under the wiper, a sign you cannot decode, a car you cannot find, a crash to document —...
Read Article →
The association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women...
Read Article →
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ -- Pharmacy leaders, invited from around the world, gathered in Montréal today for an international...
Read Article →
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate...
Read Article →
Leading the evolution of cloud-native meter data management with flexible deployment, real-time intelligence, and customer-centric innovation.SAN ANTONIO, Aug. 26, 2026...
Read Article →
SARALAND, Ala., Aug. 26, 2026 /PRNewswire/ -- As students return to school, parents are busy with supply lists, shopping for...
Read Article →
This recognition highlights CHT Security's leadership in AI-enabled security operations, cyber resilience, and customer-centric cybersecurity services that support secure digital...
Read Article →
- ASP2138's advancement into Phase 3 marks an important milestone in Astellas' commitment to advancing research in CLDN18.2 with its...
Read Article →
TAIPEI, Aug. 23, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today...
Read Article →